Lowe Thomas G, Coe Jeffrey D
Woodbridge Orthopaedic Spine Specialists, Wheat Ridge, Colo, USA.
Orthopedics. 2002 Oct;25(10 Suppl):s1179-83; discussion s1183. doi: 10.3928/0147-7447-20021002-09.
Sixty patients from two centers have undergone instrumented transforaminal posterior lumbar interbody fusion (TLIF) with bioresorbable polymer cages and autograft bone for degenerative indications. This article discusses the technique of TLIF and its early outcomes. Although follow-up is short and results are preliminary, no adverse events or complications may be attributed to the bioresorbable polymer. Further multicenter clinical studies are underway with a minimum of 2 years of follow-up chosen as an endpoint to provide insight as to the future of biodegradable polymers as spinal interbody devices.
来自两个中心的60例患者因退行性疾病接受了使用可生物吸收聚合物椎间融合器和自体骨的经椎间孔腰椎后路椎间融合术(TLIF)。本文讨论了TLIF技术及其早期疗效。尽管随访时间短且结果是初步的,但未发现任何不良事件或并发症可归因于可生物吸收聚合物。目前正在进行进一步的多中心临床研究,选择至少2年的随访作为终点,以深入了解可生物降解聚合物作为脊柱椎间植入装置的未来前景。